Off-label indications for medication use and the published literature

被引：1
|
作者：
Dresser, Rebecca [1 ]
机构：
[1] Washington Univ, Sch Law, St Louis, MO 63130 USA
来源：
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2008年 / 300卷 / 12期
关键词：
D O I：
10.1001/jama.300.12.1411-b
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
下载
收藏
页码：1411 / 1411
页数：1
相关论文
共 50 条
  • [31] OFF-LABEL MEDICATION USE IN ADULT CRITICAL CARE PATIENTS.
    Lat, Ishaq
    Micek, Scott
    Cohen, Henry
    Olsen, Keith
    Haas, Curtis
    CRITICAL CARE MEDICINE, 2008, 36 (12) : A85 - A85
  • [32] Prevalence of medication and off-label medication use in acquired brain injury at a neurorehabilitation hospital
    Raquel Merino
    Ana Pérez
    Josana Fierro
    Rosa Terré
    European Journal of Clinical Pharmacology, 2019, 75 : 985 - 994
  • [33] Addressing innovative off-label medication use at an academic medical center
    Skledar, Susan J.
    Corman, Shelby L.
    Smitherman, Thomas
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2015, 72 (06) : 469 - 477
  • [34] DISSEMINATION OF INFORMATION ON THE OFF-LABEL (UNAPPROVED) USE OF MEDICATION: A COMPARATIVE ANALYSIS
    Jansen, Rita-Marie
    MEDICINE AND LAW, 2011, 30 (01): : 115 - 132
  • [35] Off-label medication use in rare pediatric diseases in the United States
    Fung, Albert
    Yue, Xiaomeng
    Wigle, Patricia R.
    Guo, Jeff J.
    INTRACTABLE & RARE DISEASES RESEARCH, 2021, 10 (04) : 238 - 245
  • [36] A MULTICENTER EVALUATION OF EVIDENCE SUPPORTING ICU OFF-LABEL MEDICATION USE
    Smithburger, Pamela
    Buckley, Mitchell
    Lac, Ishaq
    Kane-Gill, Sandra
    CRITICAL CARE MEDICINE, 2014, 42 (12)
  • [37] Use of Rituximab as an Off-Label Medication in Glomerular Diseases: Clinical Perspective
    AlSahow, Ali
    Al-Muhaiteeb, Abdullah
    Nawar, Hani
    AlHelal, Bassam
    AlYousef, Anas
    Abdallah, Emad
    AbuShall, Ahmad
    Elmekawi, Sameh
    Meshal, Basem
    AlQallaf, Ahmed
    AlRajab, Heba
    MEDICAL PRINCIPLES AND PRACTICE, 2022, 31 (02) : 133 - 141
  • [38] Off-label use and G-BA. Legal framework for off-label use
    Brucklacher, U.
    Brockmeyer, N. H.
    Riedel, C.
    HAUTARZT, 2013, 64 (10): : 736 - 742
  • [39] Off-label drug use in oncology: a systematic review of literature
    Saiyed, M. M.
    Ong, P. S.
    Chew, L.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2017, 42 (03) : 251 - 258
  • [40] Off-Label Antidepressant Use
    Schaefer, Wiebke
    Kollhorst, Bianca
    Reinders, Tammo
    Riedel, Oliver
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2017, 26 : 465 - 466
12345